COVID-19: Transmission, prevention, and potential therapeutic opportunities

M Lotfi, MR Hamblin, N Rezaei - Clinica chimica acta, 2020 - Elsevier
The novel coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Despite intense …

Overview of immune response during SARS-CoV-2 infection: lessons from the past

VK Shah, P Firmal, A Alam, D Ganguly… - Frontiers in …, 2020 - frontiersin.org
After the 1918 flu pandemic, the world is again facing a similar situation. However, the
advancement in medical science has made it possible to identify that the novel infectious …

Potential interventions for novel coronavirus in China: A systematic review

L Zhang, Y Liu - Journal of medical virology, 2020 - Wiley Online Library
An outbreak of a novel coronavirus (COVID‐19 or 2019‐CoV) infection has posed significant
threats to international health and the economy. In the absence of treatment for this virus …

Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019‐nCoV

JS Morse, T Lalonde, S Xu, WR Liu - Chembiochem, 2020 - Wiley Online Library
With the current trajectory of the 2019‐nCoV outbreak unknown, public health and medicinal
measures will both be needed to contain spreading of the virus and to optimize patient …

[HTML][HTML] Traditional Chinese medicine in COVID-19

M Lyu, G Fan, G Xiao, T Wang, D Xu, J Gao… - … Pharmaceutica Sinica B, 2021 - Elsevier
COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread across the globe, posing an enormous threat to public health and safety …

[HTML][HTML] Molecular immune pathogenesis and diagnosis of COVID-19

X Li, M Geng, Y Peng, L Meng, S Lu - Journal of pharmaceutical analysis, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of …

Medicinal plants as sources of active molecules against COVID-19

B Benarba, A Pandiella - Frontiers in pharmacology, 2020 - frontiersin.org
The Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) or novel
coronavirus (COVID-19) infection has been declared world pandemic causing a worrisome …

Natural products for COVID‐19 prevention and treatment regarding to previous coronavirus infections and novel studies

M Boozari, H Hosseinzadeh - Phytotherapy Research, 2021 - Wiley Online Library
Recently, the novel life‐threatening coronavirus infection (COVID‐19) was reported at the
end of 2019 in Wuhan, China, and spread throughout the world in little time. The effective …

Drug development and medicinal chemistry efforts toward SARS‐coronavirus and Covid‐19 therapeutics

AK Ghosh, M Brindisi, D Shahabi… - …, 2020 - Wiley Online Library
The COVID‐19 pandemic caused by SARS‐CoV‐2 infection is spreading at an alarming
rate and has created an unprecedented health emergency around the globe. There is no …

Caffeoylquinic acids: Chemistry, biosynthesis, occurrence, analytical challenges, and bioactivity

A Alcázar Magaña, N Kamimura… - The plant …, 2021 - Wiley Online Library
Caffeoylquinic acids (CQAs) are specialized plant metabolites we encounter in our daily life.
Humans consume CQAs in mg‐to‐gram quantities through dietary consumption of plant …